Wellington Management Group’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Sell
25,785
-2,608
-9% -$193K ﹤0.01% 1580
2025
Q4
$2.24M Sell
28,393
-1,366
-5% -$93.1K ﹤0.01% 1574
2025
Q3
$1M Buy
+29,759
New +$733K ﹤0.01% 1776
2024
Q3
Sell
-31,678
Closed -$449K 1968
2024
Q2
$449K Buy
+31,678
New +$495K ﹤0.01% 1786

Other funds holding INBX

Wellington Management Group's INBX Position: Q1 2026 in Review

Wellington Management Group reduced its Inhibrx (INBX) stake by 9.2% in Q1 2026, selling an estimated $193K and leaving 25,785 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Wellington Management Group first reported a position in INBX in Q2 2024 and has held it in 4 quarters since. The position peaked at $2.24M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Wellington Management Group held 25,785 shares of Inhibrx worth $1.73M as of Q1 2026.
  • Wellington Management Group sold 2,608 Inhibrx shares in Q1 2026, an estimated $193K.
  • Inhibrx made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1580 holding.
  • Wellington Management Group first reported a position in Inhibrx in Q2 2024 and has held it in 4 quarters since.
  • Wellington Management Group's Inhibrx position peaked at $2.24M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.